Dalteparin: all 52 studies that test it

Page 1 of 1. Open to participants first (5), then studies with results posted, then the rest; newest registration first within each.

• Thromboprophylaxis in Lower Limb ImmobilisationRecruitingNCT06370273Phase 3
• THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE)RecruitingNCT05735639Phase 4
• STrategies for Anticoagulation in Patients With thRombocytopenia and Cancer-associated ThrombosisRecruitingNCT05255003Phase 4
• Pre- Vs. Postoperative Thromboprophylaxis in Pancreatic SurgeryRecruitingNCT05245877Phase 4
• PROphylaxis for Venous ThromboEmbolism in Severe Traumatic Brain Injury (PROTEST)RecruitingNCT03559114Phase 3
• Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in CancerCompletedNCT02744092Not applicableResults posted
• Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous ThromboembolismCompletedNCT02585713Phase 3Results posted
• Use Of Fragmin In HemodialysisCompletedNCT01879618Phase 3Results posted
• Treatment of Sickle Cell Patients Hospitalized in Pain Crisis With Prophylactic Dose Low-molecular-weight Heparin (LMWH) Versus PlaceboCompletedNCT01419977Phase 2Results posted
• PROSPER: PostpaRtum PrOphylaxiS for PE Randomized Control Trial PilotCompletedNCT01274637Phase 3Results posted
• The Clinical Utility of Thrombelastography in Guiding Prophylaxis of Venous Thromboembolism Following TraumaCompletedNCT01050153Not applicableResults posted
• Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer PatientsCompletedNCT00966277Phase 4Results posted
• Fragmin for the Treatment of Acute VTE in Pediatric Cancer PatientsCompletedNCT00952380Phase 2Results posted
• Evaluation of Dalteparin for Long-term (One Year) Treatment of Blood Clots in Subjects With CancerCompletedNCT00942968Phase 4Results posted
• A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer PatientsTerminatedNCT00876915Phase 3Results posted
• Effectiveness of Bridging Anticoagulation for Surgery (The BRIDGE Study)CompletedNCT00786474Phase 3Results posted
• The Effect Of Fragmin In The Treatment Of Neuroischaemic Foot Ulcers In Diabetic Patients (A6301086)CompletedNCT00765063Phase 2/3Results posted
• Study Of The Effect Of Fragmin In The Treatment Of Neuroischaemic Foot Ulcers In Diabetic PatientsCompletedNCT00662831Phase 2/3Results posted
• Dalteparin in Preventing DVT in Participants With CancerCompletedNCT00525057Not applicableResults posted
• Dalteparin vs Unfractionated Heparin For The Prevention Of Venous Thromboembolism (VTE) In Hospitalized Acutely Ill Medical PatientsTerminatedNCT00445328Phase 4Results posted
• Dalteparin Versus Unfractionated Heparin In Patients With Acute Coronary SyndromeTerminatedNCT00435487Phase 4Results posted
• Management of Superficial ThrombophlebitisCompletedNCT00264381Phase 4Results posted
• Treatment of Upper Extremity Deep-Vein ThrombosisCompletedNCT00245856Phase 4Results posted
• Causes and Prevention of Thromboembolic Disease in Nephrotic SyndromeCompletedNCT04850378Phase 1/2
• Australasian COVID-19 Trial (ASCOT) ADAptive Platform TrialActive, not recruitingNCT04483960Phase 3
• WAVe Study - Weight Adjusted Dalteparin for Patients Over 90 kg With Acute Cancer Associated Venous ThromboembolismTerminatedNCT03297359Phase 2
• A New Anticoagulation Method Using Dalteparin in Quotidian and Nocturnal Home Hemodialysis PatientsCompletedNCT02607111Phase 4
• Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic SurgeryCompletedNCT02334007Phase 1/2
• Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in PregnancyCompletedNCT01828697Phase 4
• Coagulation Profile in Patients Undergoing Video Assisted Thorascopic Surgery (VATS) for Lung CancerCompletedNCT01741506Phase 4
• Preoperative Versus Postoperative Start With Thromboprophylaxis in THA (Total Hip Arthroplasty)CompletedNCT01714297Phase 4
• Dalteparin, Lenalidomide, and Low-Dose Dexamethasone in Treating Patients With Previously Untreated Multiple MyelomaTerminatedNCT01518465Phase 2
• Efficacy of Low Molecular Weight Heparin in Superficial Vein ThrombosisCompletedNCT01245998Phase 4
• Dalteparin and Sunitinib Malate as First-Line Therapy in Treating Patients With Kidney Cancer That is Metastatic or Cannot Be Removed by SurgeryCompletedNCT01061411Phase 1
• TIPPS: Thrombophilia in Pregnancy Prophylaxis StudyCompletedNCT00967382Phase 3
• Thrombophylaxis in Transurethral Surgery With DalteparineCompletedNCT00681785Not applicable
• Prophylaxis In Venous Thromboembolism In Primary Care, A Pilot StudyTerminatedNCT00655122Phase 4
• Dalteparin in Preventing Blood Clots in Patients With Lung CancerStatus unknownNCT00519805Phase 3
• Gemcitabine With or Without Dalteparin in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerCompletedNCT00462852Phase 2
• Thromboprophylaxis in Critically Ill PatientsTerminatedNCT00437697Phase 4
• Effectiveness of Dalteparin Therapy as Intervention in Recurrent Pregnancy LossCompletedNCT00400387Phase 3
• FOLFIRI + Bevacizumab With or Without Dalteparin in First Line Treatment of Advanced Colorectal CancerTerminatedNCT00323011Phase 2
• A Comparison of Dalteparin and Tinzaparin for Prevention of Blood Clots in Hemodialysis Patients on Oral Anticoagulants Having SurgeryCompletedNCT00260988Phase 2/3
• Fragmin in Ovarian Cancer: Utility on Survival (FOCUS)CompletedNCT00239980Phase 2
• The Catheter Study: Central Venous Catheter Survival in Cancer Patients Using Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein ThrombosisCompletedNCT00216866Phase 2
• PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT Pilot)CompletedNCT00182364Phase 3
• Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour PatientsCompletedNCT00135876Phase 3
• Outpatient Treatment Of Deep Venous Thrombosis Using Subcutaneous Dalteparin (Fragmin) In Low Risk Cancer PatientsTerminatedNCT00041782Phase 2
• Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic CancerTerminatedNCT00031837Phase 3
• Dalteparin and Radiation Therapy in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma MultiformeCompletedNCT00028678Phase 2
• Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a CatheterCompletedNCT00006083Phase 3
• Standard Therapy With or Without Dalteparin in Treating Patients With Advanced Breast, Lung, Colorectal, or Prostate CancerCompletedNCT00003674Phase 3

← Dalteparin overview